Skip to main content

Industry Events

Industry symposia will be held in conjunction with the STS Annual Meeting and are not part of the official STS scientific program. Continuing Medical Education (CME) credit for these activities is not offered by STS.

Industry Events

  • Thursday, January 23, 2025
  • 11:45am - 12:45pm PT
    Thoraflex™ Hybrid – Conforming Arch Surgery to the Gold Standard
  • 11:45am - 12:45pm PT
    Treatment Options for Patients with Resectable NSCLC
  • Friday, January 24, 2025
  • 11:55am - 12:55pm PT
    A Treatment Option for Certain Patients With Resectable Non-Small Cell Lung Cancer (NSCLC)
  • 11:55am - 12:55pm PT
    Paradigm Shift: Heart Recovery with Impella 5.5 with Smart Assist
  • 11:55am - 12:55pm PT
    Revolutionary Clinical Trials in Arrhythmia and LAA Management Results and Impact on Practice - CME note provided by STS
  • 11:55am - 12:55pm PT
    Revolutionizing Mitral Valve Replacement with EPIC Plus: Delivering Durability, Implantability, and a Path for Future Interventions
  • 11:55am - 12:55pm PT
    TEVAR Innovations for Arch Applications
  • 12:00pm - 12:45pm PT
    Glimpse into the Future: Pioneering Breakthroughs in Lung Cancer Diagnosis and Therapy
  • 6:15pm - 7:45pm PT
    Disrupting the Status Quo in Cardiac and Thoracic Perioperative Care
  • 6:15pm - 7:45pm PT
    Intuitive Surgical Industry Symposium, Non-CME
  • 6:15pm - 8:30pm PT
    Integrating Surgery and Systemic Therapy for Resectable NSCLC
  • Saturday, January 25, 2025
  • 6:00am - 7:00am PT
    ALECENSA: The First and Only Adjuvant Treatment for Patients with Resectable ALK + NSCLC
  • 6:00am - 7:00am PT
    What you need to know for mitral valve lifetime management. Durability, hemodynamics and the MITRIS RESILIA valve.
  • 6:00am - 7:00am PT
    When Every Second Counts: The Latest Data and Expert Guidance on Antiplatelet Therapy Reversal for Surgical Professionals
  • 11:55am - 12:55pm PT
    Artivion Industry Symposium, Non-CME
  • 11:55am - 12:55pm PT
    Edwards Lifesciences Industry Symposium, Non-CME
  • 11:55am - 12:55pm PT
    Optimizing The Care Pathway For Younger Patients – The Role of Mechanical Valves in the TAVR Era
  • 11:55am - 12:55pm PT
    Perioperative Immunotherapy + Neoadjuvant Platinum-Containing Chemotherapy for the Treatment of Resectable NSCLC
  • 11:55am - 12:55pm PT
    Targeting Higher Standards in Resectable NSCLC: The Surgery-Oncology Coalition for Tailoring Care in EGFR & ALK TKI Therapy
  • 5:00pm - 6:30pm PT
    Comprehensive Solution for Cardiac Procedures
  • 5:45pm - 6:45pm PT
    Mastering the Integration of Immunotherapy in Resectable NSCLC: Practical Considerations for Real-World Practice